Home

Venrock Healthcare Capital Partners III, 10% Owner: KalVista Pharmaceuticals KALV Buy · Filed 24/01/19

Trade details

Type
Insider buy
Amount
$994,455
Shares · price
78,925 sh · $12.60 a share
Held after
4,394,971 sh
Trade date
24/01/17
Filed
24/01/19
Days to filing
2 days

First buy since 2023

Insiders buying this week
7 insiders
Holding change
+1.8%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/18~24/02/16

Venrock Healthcare Capital Partners III's recent trades